Literature DB >> 14500626

Cutting edge: signaling and cell surface expression of a mu H chain in the absence of lambda 5: a paradigm revisited.

Wolfgang Schuh1, Silke Meister, Edith Roth, Hans-Martin Jäck.   

Abstract

Pre-B cell receptor (pre-BCR) signals are essential for pro-B cells to mature efficiently into pre-B cells. The pre-BCR is an Ig-like transmembrane complex that is assembled from two mu H chains (mu HC) and two surrogate L chains consisting of the non-covalently associated polypeptides VpreB and lambda5. In lambda5(-/-) mice, pro-B cell maturation is impaired, but not completely blocked, implying that a mu HC induces differentiation signals in the absence of lambda5. Using a mouse model, in which transgenic mu HC expression can be controlled by tetracycline, we show that in the absence of lambda5, the transgenic mu HC promotes in vivo differentiation of pro-B cells, induces IL-7-dependent cell growth, and is expressed on the surface of pre-B cells. Our findings not only show that an incomplete pre-BCR can initiate signals, but also challenge the paradigm that an IgHC must associate with an IgLC or a SLC to gain transport and signaling competency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500626     DOI: 10.4049/jimmunol.171.7.3343

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

2.  Equal transcription rates of productively and nonproductively rearranged immunoglobulin mu heavy chain alleles in a pro-B cell line.

Authors:  Andrea B Eberle; Kai Herrmann; Hans-Martin Jäck; Oliver Mühlemann
Journal:  RNA       Date:  2009-04-10       Impact factor: 4.942

Review 3.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

4.  N-linked glycosylation selectively regulates autonomous precursor BCR function.

Authors:  Rudolf Ubelhart; Martina P Bach; Cathrin Eschbach; Thomas Wossning; Michael Reth; Hassan Jumaa
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

5.  Loss of an Igκ gene enhancer in mature B cells results in rapid gene silencing and partial reversible dedifferentiation.

Authors:  Xiaorong Zhou; Yougui Xiang; Xiaoling Ding; William T Garrard
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

6.  In old BALB/c mice, bone marrow pre-B cell and surrogate light chain reduction is associated with increased B cell reactivity to phosphorylcholine, but reduced T15 idiotype dominance.

Authors:  Kelly Khomtchouk; Sarah Alter; Michelle Ratliff; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2016-11-19       Impact factor: 5.432

7.  A VpreB3 homologue in a marsupial, the gray short-tailed opossum, Monodelphis domestica.

Authors:  Xinxin Wang; Zuly E Parra; Robert D Miller
Journal:  Immunogenetics       Date:  2012-06-09       Impact factor: 2.846

8.  Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.

Authors:  Silke Meister; Benjamin Frey; Veronika R Lang; Udo S Gaipl; Georg Schett; Ursula Schlötzer-Schrehardt; Reinhard E Voll
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

9.  Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment.

Authors:  Christian A J Vosshenrich; Ana Cumano; Werner Müller; James P Di Santo; Paulo Vieira
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

10.  Two distinct populations of H chain-edited B cells show differential surrogate L chain dependence.

Authors:  Pamela B Nakajima; Kerstin Kiefer; Amy Price; Gayle C Bosma; Melvin J Bosma
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.